An experimental drug from Eli Lilly https://www.reuters.com/markets/companies/LLY.N” target=”_blank” rel=”noopener”>(LLY.N) works best if Alzheimer’s patients are treated as early as possible, ideally before they develop symptoms of the brain-wasting disease, r…
Read More
About The Author
